As of 2025-12-12, the Relative Valuation of Abbott Laboratories (ABT) is 217.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 123.28 USD, the upside of Abbott Laboratories based on Relative Valuation is 76.2%.
The range of the Relative Valuation is 127.99 - 327.47 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.1x - 40.7x | 36.5x |
| Forward P/E multiples | 30.7x - 36.3x | 33.8x |
| Fair Price | 127.99 - 327.47 | 217.20 |
| Upside | 3.8% - 165.6% | 76.2% |
| Date | P/E |
| 2025-12-11 | 15.34 |
| 2025-12-10 | 15.25 |
| 2025-12-09 | 15.08 |
| 2025-12-08 | 15.19 |
| 2025-12-05 | 15.56 |
| 2025-12-04 | 15.60 |
| 2025-12-03 | 15.59 |
| 2025-12-02 | 15.72 |
| 2025-12-01 | 15.93 |
| 2025-11-28 | 16.04 |
| 2025-11-26 | 15.99 |
| 2025-11-25 | 15.93 |
| 2025-11-24 | 15.82 |
| 2025-11-21 | 15.94 |
| 2025-11-20 | 15.42 |
| 2025-11-19 | 15.69 |
| 2025-11-18 | 16.17 |
| 2025-11-17 | 16.18 |
| 2025-11-14 | 16.25 |
| 2025-11-13 | 16.08 |
| 2025-11-12 | 16.03 |
| 2025-11-11 | 15.80 |
| 2025-11-10 | 15.66 |
| 2025-11-07 | 15.72 |
| 2025-11-06 | 15.54 |
| 2025-11-05 | 15.49 |
| 2025-11-04 | 15.65 |
| 2025-11-03 | 15.41 |
| 2025-10-31 | 15.38 |
| 2025-10-30 | 15.51 |
| 2025-10-29 | 15.48 |
| 2025-10-28 | 15.75 |
| 2025-10-27 | 15.82 |
| 2025-10-24 | 15.78 |
| 2025-10-23 | 15.72 |
| 2025-10-22 | 15.92 |
| 2025-10-21 | 15.87 |
| 2025-10-20 | 16.11 |
| 2025-10-17 | 15.99 |
| 2025-10-16 | 15.88 |
| 2025-10-15 | 16.10 |
| 2025-10-14 | 16.58 |
| 2025-10-13 | 16.34 |
| 2025-10-10 | 16.49 |
| 2025-10-09 | 16.59 |
| 2025-10-08 | 16.70 |
| 2025-10-07 | 16.55 |
| 2025-10-06 | 16.64 |
| 2025-10-03 | 16.74 |
| 2025-10-02 | 16.55 |